Ken Imai

Ken Imai is currently a Clinical Director of Oncology at Merck, where they have been contributing to oncology clinical development since 2018. They previously served as a Drug Safety Medical Doctor at MSD and gained experience as a Research Intern at the Centers for Disease Control and Prevention. Ken practiced as an Internal Medicine and Infectious Disease Physician at the Institute of Medical Science, University of Tokyo, and as an Internal Medicine Physician at The University of Tokyo Hospital. They hold a Master of Public Health from Emory University and a Doctor of Medicine from the University of Yamanashi.